Diabetes Care Devices Market Professional Survey Report 2018

Posted October 23, 2018 by roberthenric

The Diabetes Care Devices Market is expected to reach USD 2.3 Billion and is poised to grow at a CAGR of 6.3% during the forecast period.

According to the new market research report “Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) — Forecast to 2020”, published by MarketsandMarkets™, analyzes and studies major market drivers, restraints, and opportunities in BRIC countries.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=375

The BRIC Diabetes Care Devices Market has witnessed major growth in the past few years, and is largely driven by the increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations. The rising obese population and rapid industrialization and urbanization have also contributed to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness inhibit the growth of this market.

This report also covers major market drivers, restraints, opportunities, and challenges for the BRIC Diabetes Care Devices Market.

Browse and in-depth TOC on “Diabetes Care Devices Market”

33 — Tables

37 — Figures

109 — Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/diabetes-care-375.html

The BRIC Diabetes Care Devices Market is segmented on the basis of type and country. By type, the market has been segmented into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are further classified into testing strips, self-monitoring blood glucose meters, lancets, continuous glucose monitors, and others. On the other hand, insulin drug delivery devices are subsegmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors.

In 2014, the testing strips segment accounted for the largest share of the blood glucose monitoring devices market; whereas, the insulin pens segment accounted for the largest share of the insulin delivery devices market. The large share of the insulin pens segment is mainly attributed to the high adoption rate of insulin pens in China and Russia.

Moreover, the increasing adoption of insulin pens and easy availability of recently launched affordable insulin pens in India have further contributed to the growth of this segment. Continuous blood glucose monitoring systems is the fastest-growing subsegment of the blood glucose monitoring devices market. Growth in this segment is mainly attributed to the rising adoption of continuous blood glucose monitoring systems by healthcare professionals to monitor real-time blood glucose levels for better management of diabetes.

Request for Free Sample Report @


China is estimated to be the largest market for the BRIC Diabetes Care Devices Market, followed by Brazil, India, and Russia. India is expected to witness the highest growth rate during the forecast period, due to the increasing prevalence of diabetes, lifestyle changes, and growing research on diabetes and its management.

Some of the major players in this market include Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketsandMarkets
Phone +18886006441
Business Address northbook
Country United States
Categories Biotech , Medical , Research
Tags diabetes care devices , diabetes care devices market , diabetes care devices market analysis , diabetes care devices market share , diabetes care devices market size
Last Updated October 23, 2018